Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Pulmonx (LUNG) Receivables - Net (2019 - 2025)

Pulmonx has reported Receivables - Net over the past 7 years, most recently at $12.1 million for Q4 2025.

  • Quarterly Receivables - Net fell 7.99% to $12.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.1 million through Dec 2025, down 7.99% year-over-year, with the annual reading at $12.1 million for FY2025, 7.99% down from the prior year.
  • Receivables - Net was $12.1 million for Q4 2025 at Pulmonx, down from $13.8 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $15.9 million in Q2 2025 and troughed at $5.1 million in Q1 2021.
  • The 5-year median for Receivables - Net is $9.5 million (2023), against an average of $9.9 million.
  • Year-over-year, Receivables - Net soared 55.2% in 2021 and then fell 7.99% in 2025.
  • A 5-year view of Receivables - Net shows it stood at $6.6 million in 2021, then surged by 32.23% to $8.7 million in 2022, then soared by 39.51% to $12.1 million in 2023, then increased by 8.38% to $13.1 million in 2024, then dropped by 7.99% to $12.1 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Receivables - Net are $12.1 million (Q4 2025), $13.8 million (Q3 2025), and $15.9 million (Q2 2025).